This brand name is authorized in Austria, Israel, Lithuania, Malta, Romania
The drug VIBROCIL contains a combination of these active pharmaceutical ingredients (APIs):
1
Phenylephrine
UNII 1WS297W6MV - PHENYLEPHRINE
|
Phenylephrine is a sympathomimetic agent with mainly direct effects on adrenergic receptors. It has predominantly alpha adrenergic activity and is without stimulating effects on the central nervous system. The sympathomimetic effect of phenylephrine produces vasoconstriction which in turn relieves nasal congestion. |
2
Dimetindene
UNII 6LL60J9E0O - DIMETHINDENE MALEATE
|
Dimetindene is an antihistaminic of the alkylamine group. Its action is the result of the capture of histamine Η1 subunits. It has mild anticholinergic and sedative action. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
R01AB01 | Phenylephrine | R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AB Sympathomimetics, combinations excl. corticosteroids |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 1181 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1008853, 1008854 |
Country: MT | Medicines Authority | Identifier(s): MA1177/01201 |
Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W63410001, W63451002 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.